Escolar Documentos
Profissional Documentos
Cultura Documentos
Espasmos musculares
Sntomas oculares:
Visin doble
Dolor facial
Hipoacusia
Sntomas sexuales:
Problemas de ereccin
Fingolimod (Gilenya)
Vejiga neurgena
Las mujeres
Depresin
lceras de decbito
Infecciones urinarias
Respuesta inmunitaria
Nombres alternativos
EM, Enfermedad desmielinizante
Referencias
Calabresi P. Multiple sclerosis y demyelinating conditions of the central nervous
system. En: Goldman L, Ausiello D, eds. Cecil Medicina. 23rd ed. Philadelphia,
Pa: Saunders Elsevier;2007:chap 436.
Carroll WM. Oral therapy for multiple sclerosissea change or incremental step?
N Engl J Med. 2010 Feb 4;362(5):456-8. Epub 2010 Jan 20.
Goodin DS, Cohen BA, OConnor P, et al. Therapeutics y Technology
Assessment Subcommittee of the American Academy of Neurology.
Assessment: the use of natalizumab (Tysabri) for the treatment of multiple
sclerosis (an evidence-based review): report of the Therapeutics y Technology
Assessment Subcommittee of the American Academy of Neurology. Neurology.
2008:71(10):766-73.
Farinotti M, Simi S, Di Pietrantonj C, McDowell N, Brait L, Lupo D, Filippini G.
Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev. 2007
Jan 24;(1):CD004192.
Kappos L, Freedman MS, Polman CH, et al. Effect of early versus delayed
interferon beta-1b treatment on disability after a first clinical event suggestive
of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet.
2007:370(9585):389-97.
Miller DH, Leary SM. Primary-progressive multiple sclerosis. Lancet Neurol.
2007;6:903-912.
Marriott JJ, Miyasaki JM, Gronseth G, OConnor PW; Therapeutics y Technology
Assessment Subcommittee of the American Academy of Neurology. Evidence
Report: The efficacy y safety of mitoxantrone (Novantrone) in the treatment of
multiple sclerosis: Report of the Therapeutics y Technology Assessment
Subcommittee of the American Academy of Neurology. Neurology. 2010 May
4;74(18):1463-70.
Contenido: 8 de mayo de 2010
Versin del ingls revisada por: David Zieve, MD, MHA, Director Mdico, ADAM,
Inc. Previamente revisado por Daniel B. Hoch, PhD, MD, Profesor Adjunto de
Neurologa, Harvard Facultad de Medicina, Departamento de Neurologa,
Massachusetts General Hospital.
Traducido por: DrTango, Inc.